- Estimating the proportion of pathogenic variants from breast cancer case-control data: application to calibration of ACMG/AMP variant classification criteria.
- James PA, Fortuno C, Li N, Lim BWX, Campbell IG, Spurdle AB.
- Hum Mutat. 2022 Feb 22. doi: 10.1002/humu.24357. Epub ahead of print.
- PMID: 35191126
- PubMed abstract
- Source abstract
- PARP inhibitors for metastatic castration-resistant prostate cancer: Biological rationale and current evidence.
- Bienkowski M, Tomasik B, Braun M, Jassem J.
- Cancer Treat Rev. 2022 Feb 11;104:102359. doi: 10.1016/j.ctrv.2022.102359. Epub ahead of print.
- PMID: 35190335
- PubMed abstract
- Source abstract
- Review